Hanseatic Management Services’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-11,897
Closed -$1.54M 133
2023
Q1
$1.54M Buy
+11,897
New +$1.56M 3.46% 5
2022
Q2
Sell
-12,137
Closed -$1.58M 131
2022
Q1
$1.58M Buy
12,137
+162
+1% +$21.1K 2.72% 10
2021
Q4
$1.83M Sell
11,975
-5,781
-33% -$895K 2.98% 9
2021
Q3
$2.87M Sell
17,756
-91
-0.5% -$15.3K 4.98% 5
2021
Q2
$2.92M Buy
17,847
+5,452
+44% +$840K 5.51% 5
2021
Q1
$1.87M Buy
12,395
+267
+2% +$42.4K 3.73% 8
2020
Q4
$1.84M Buy
12,128
+24
+0.2% +$3.43K 3.95% 6
2020
Q3
$1.64M Buy
12,104
+2,554
+27% +$346K 3.7% 6
2020
Q2
$1.3M Buy
9,550
+6,508
+214% +$830K 1.1% 23
2020
Q1
$328K Buy
3,042
+3,012
+10,040% +$347K 0.35% 89
2019
Q4
$4K Buy
+30
New +$3.35K ﹤0.01% 197

Other funds holding IBB

Hanseatic Management Services's IBB Position: Q2 2023 in Review

Hanseatic Management Services sold out of iShares Biotechnology ETF (IBB) in Q2 2023, closing a stake of 11,897 shares — an estimated $1.54M sold.

Hanseatic Management Services first reported a position in IBB in Q4 2019 and held it in 11 quarters. The position peaked at $2.92M in Q2 2021. 843 funds tracked by Wall St. Rank hold IBB as of Q2 2023.

  • Hanseatic Management Services reported no remaining iShares Biotechnology ETF position as of Q2 2023 after selling out during the quarter.
  • Hanseatic Management Services sold 11,897 iShares Biotechnology ETF shares in Q2 2023, an estimated $1.54M.
  • Hanseatic Management Services first reported a position in iShares Biotechnology ETF in Q4 2019 and held it in 11 quarters.
  • Hanseatic Management Services's iShares Biotechnology ETF position peaked at $2.92M in Q2 2021.
  • 843 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2023.

Based on Hanseatic Management Services's 13F filing for Q2 2023, filed 26 Jul 2023.